These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38630860)

  • 21. Formulation techniques for high dose dry powders.
    Brunaugh AD; Smyth HDC
    Int J Pharm; 2018 Aug; 547(1-2):489-498. PubMed ID: 29778822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a Carrier Free Dry Powder Inhalation Formulation of Ketotifen for Pulmonary Drug Delivery.
    Azari F; Ghanbarzadeh S; Safdari R; Yaqoubi S; Adibkia K; Hamishehkar H
    Drug Res (Stuttg); 2020 Jan; 70(1):26-32. PubMed ID: 31533157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dry powder inhalation, part 2: the present and future.
    de Boer AH; Hagedoorn P; Grasmeijer F
    Expert Opin Drug Deliv; 2022 Sep; 19(9):1045-1059. PubMed ID: 35984322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.
    Li X; Vogt FG; Hayes D; Mansour HM
    J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):81-93. PubMed ID: 24502451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
    Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility of spray drying bacteriophages into respirable powders to combat pulmonary bacterial infections.
    Vandenheuvel D; Singh A; Vandersteegen K; Klumpp J; Lavigne R; Van den Mooter G
    Eur J Pharm Biopharm; 2013 Aug; 84(3):578-82. PubMed ID: 23353012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique with commonly prescribed dry powder inhalers in three European countries.
    Lewis A; Torvinen S; Dekhuijzen PN; Chrystyn H; Watson AT; Blackney M; Plich A
    BMC Health Serv Res; 2016 Jul; 16():251. PubMed ID: 27406133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying the features of an easy-to-use and intuitive dry powder inhaler for asthma and chronic obstructive pulmonary disease therapy: results from a 28-day device handling study, and an airflow resistance study.
    Virchow JC; Weuthen T; Harmer QJ; Jones S
    Expert Opin Drug Deliv; 2014 Dec; 11(12):1849-57. PubMed ID: 25151851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung Deposition and Inspiratory Flow Rate in Patients with Chronic Obstructive Pulmonary Disease Using Different Inhalation Devices: A Systematic Literature Review and Expert Opinion.
    Baloira A; Abad A; Fuster A; García Rivero JL; García-Sidro P; Márquez-Martín E; Palop M; Soler N; Velasco JL; González-Torralba F
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1021-1033. PubMed ID: 33907390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimizing drug delivery in COPD: The role of inhaler devices.
    Rogliani P; Calzetta L; Coppola A; Cavalli F; Ora J; Puxeddu E; Matera MG; Cazzola M
    Respir Med; 2017 Mar; 124():6-14. PubMed ID: 28284323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
    Li X; Vogt FG; Hayes D; Mansour HM
    Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carrier free indomethacin microparticles for dry powder inhalation.
    Ceschan NE; Bucalá V; Mateos MV; Smyth HDC; Ramírez-Rigo MV
    Int J Pharm; 2018 Oct; 549(1-2):169-178. PubMed ID: 30071308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Device errors in asthma and COPD: systematic literature review and meta-analysis.
    Chrystyn H; van der Palen J; Sharma R; Barnes N; Delafont B; Mahajan A; Thomas M
    NPJ Prim Care Respir Med; 2017 Apr; 27(1):22. PubMed ID: 28373682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Demystifying Dry Powder Inhaler Resistance with Relevance to Optimal Patient Care.
    Capstick TGD; Gudimetla S; Harris DS; Malone R; Usmani OS
    Clin Drug Investig; 2024 Feb; 44(2):109-114. PubMed ID: 38198116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating dry powder inhalers: From in vitro studies to mobile health technologies.
    Ari A; Alhamad BR
    Respir Med; 2023; 215():107281. PubMed ID: 37244487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dry powder inhalers for optimal drug delivery.
    Newman SP
    Expert Opin Biol Ther; 2004 Jan; 4(1):23-33. PubMed ID: 14680466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smart dry powder inhalers and intelligent adherence management.
    Häußermann S; Arendsen LJ; Pritchard JN
    Adv Drug Deliv Rev; 2022 Dec; 191():114580. PubMed ID: 36273513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Evolution of Pressurized Metered-Dose Inhalers from Early to Modern Devices.
    Roche N; Dekhuijzen PN
    J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):311-27. PubMed ID: 26824873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High inhaler resistance does not limit successful inspiratory maneuver among patients with asthma or COPD.
    Vartiainen VA; Lavorini F; Murphy AC; Rabe KF
    Expert Opin Drug Deliv; 2023 Mar; 20(3):385-393. PubMed ID: 36820500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Powder Production and Particle Engineering for Dry Powder Inhaler Formulations.
    Lin YW; Wong J; Qu L; Chan HK; Zhou QT
    Curr Pharm Des; 2015; 21(27):3902-16. PubMed ID: 26290193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.